It was found that mild COVID-19 cases were more associated with a robust expansion of CD8+ Trm compared to more severe cases, suggesting a role for SARS-CoV-2-specific Trm in the mitigation of COVID-19 pathogenesis (64). The gene discussed is CD8A; the disease is COVID-19.